Kalaris Therapeutics KLRS
NASDAQ KLRS
$1.90 +0.03 (+1.60%)
At close: Nov 11, 2026 · 4:00 PM EST

Kalaris Therapeutics (KLRS) Ending Cash Balance (2019 - 2026)

Updated

Analysis

Kalaris Therapeutics (KLRS) Ending Cash Balance (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 16.91 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 10.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 9.65 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 7.94 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 6.44 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.88 Bn
10 Kalaris Therapeutics 44.52 Mn -38.38 Mn - 47.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 47.88 Mn
Jun 30, 2026 43.67 Mn
Mar 31, 2026 34.93 Mn
Dec 31, 2025 98.55 Mn
Sep 30, 2025 42.89 Mn
Jun 30, 2025 88.93 Mn
Mar 31, 2025 101.47 Mn
Dec 31, 2024 1.64 Mn
Sep 30, 2024 1.91 Mn
Jun 30, 2024 6.24 Mn
Mar 31, 2024 5.23 Mn
Dec 31, 2023 3.17 Mn
Sep 30, 2023 96.48 Mn
Jun 30, 2023 197.81 Mn
Mar 31, 2023 116.55 Mn
Dec 31, 2022 106.94 Mn
Sep 30, 2022 124.69 Mn
Jun 30, 2022 71.95 Mn
Mar 31, 2022 101.06 Mn
Dec 31, 2021 202.51 Mn
API Access

Kalaris Therapeutics Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=KLRS&period=max&api_key=YOUR_API_KEY